Markets are Closed
Company Logo
ELGX
Endologix Inc.

Open

Previous Open

High

Previous High

Low

Previous Low

Close

Previous Close

Volume

Previous Volume

Company Profile

Description

Endologix Inc develops, manufactures, markets and sells medical devices for the treatment of aortic disorders. Its products are intended for the treatment of abdominal aortic aneurysms.

Exchange

Nasdaq Global Select

List Date

June 21, 1996

CEO

John Onopchenko

Employees

675

Financials

Revenue

143.37M

Earnings

-34.50M
212M
128M
43M
-40M
-124M
2015
2016
2017
2018

Splits

March 06, 201910.00%

Dividends

No dividends paid to date

Related News

News post image: Endologix Adds Jane E. Kiernan to its Board of Directors
Endologix Adds Jane E. Kiernan to its Board of Directors
Mar 17, 2020 @ 22:30
Endologix, Inc. (Nasdaq: ELGX) ("Endologix" or the "Company"), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Jane E. Kiernan to its board of directors, effective March 12, 2020. Ms. Kiernan has also been appointed to...
finance yahoo
News post image: Endologix Receives FDA Approval for Alto Abdominal Stent Graft System
Endologix Receives FDA Approval for Alto Abdominal Stent Graft System
Mar 16, 2020 @ 13:00
Endologix® Inc. (Nasdaq: ELGX) ("Endologix" or the "Company"), a developer and marketer of innovative treatments for aortic disorders, today announced that it has received approval from the United States Food and Drug Administration (FDA) for the Alto™ Abdominal Stent Graft System...
finance yahoo
News post image: Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Endologix Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar 06, 2020 @ 13:00
Endologix, Inc. (Nasdaq: ELGX) (the "Company"), a developer and marketer of innovative treatments for aortic disorders, announced today the grant of an inducement equity award to a newly hired employee (the "Awardee"). The award was approved by the Company’s Compensation Committee...
finance yahoo
News post image: Is the Options Market Predicting a Spike in Endologix (ELGX) Stock?
Is the Options Market Predicting a Spike in Endologix (ELGX) Stock?
Feb 27, 2020 @ 13:39
Investors need to pay close attention to Endologix (ELGX) stock based on the movements in the options market lately....
finance yahoo
News post image: Endologix Announces Debt Restructuring Addressing 2020 Maturities
Endologix Announces Debt Restructuring Addressing 2020 Maturities
Feb 24, 2020 @ 13:55
Endologix, Inc. (Nasdaq: ELGX) ("Endologix" or the "Company"), a developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into an exchange agreement with three holders of the Company’s 3.25% Senior Convertible Notes due 2020 (the "...
finance yahoo
News post image: Edited Transcript of ELGX earnings conference call or presentation 19-Feb-20 9:30pm GMT
Edited Transcript of ELGX earnings conference call or presentation 19-Feb-20 9:30pm GMT
Feb 22, 2020 @ 23:01
Q4 2019 Endologix Inc Earnings Call...
finance yahoo
News post image: Endologix, Inc. Just Reported, And Analysts Assigned A US$3.80 Price Target
Endologix, Inc. Just Reported, And Analysts Assigned A US$3.80 Price Target
Feb 22, 2020 @ 13:45
Last week, you might have seen that Endologix, Inc. (NASDAQ:ELGX) released its full-year result to the market. The......
finance yahoo
News post image: Endologix (ELGX) Reports Q4 Loss, Misses Revenue Estimates
Endologix (ELGX) Reports Q4 Loss, Misses Revenue Estimates
Feb 19, 2020 @ 22:15
Endologix (ELGX) delivered earnings and revenue surprises of 40.00% and -0.14%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?...
finance yahoo
News post image: Endologix Reports Fourth Quarter and Fiscal Year 2019 Financial Results
Endologix Reports Fourth Quarter and Fiscal Year 2019 Financial Results
Feb 19, 2020 @ 21:01
Endologix, Inc. (the "Company") (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019....
finance yahoo
News post image: Endologix, Inc. to Present at the SVB Leerink Global Healthcare Conference
Endologix, Inc. to Present at the SVB Leerink Global Healthcare Conference
Feb 18, 2020 @ 13:00
Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. ET on Wednesday, February 26, 2020 in New York, NY...
finance yahoo
All data provided on Polygon is provided for informational purposes only, and is not intended for trading or investing purposes.
Copyright © 2021, Polygon.io, Inc. All Rights Reserved.
TradingView Lightweight Chart: Copyright (с) 2020 TradingView, Inc. https://www.tradingview.com/